Head of Science Department
Medicines Evaluation Board
Marjon Pasmooij, is head of the Science Department at the Dutch Medicines Evaluation Board (MEB) and co-chair of the Regulatory Science Network Netherlands (RSNN). Marjon studied Cell Biology in Wageningen, and did her PhD at the Dermatology Department of the University Medical Center Groningen on a rare genetic skin disease. Marjon has been employed by the MEB in various roles since 2007. She worked as a clinical assessor for 10 years in the field of gynaecology and dermatology. Since 2018 she is heading the Science Department, and coordinating the Regulatory Science activities where the MEB is involved in (about 15 PhD projects, and 20-25 Master students yearly). She is also part of the EMA-HMA EU-Innovation Network, which facilitates the development of innovative medicines and associated technologies and aims to strengthen engagement with innovators, and a member of the EMA-HMA Big Data Steering Group that is working on the 10 priority recommendations regarding Big Data, including having skills to perform analyses on Big Data within the network
Disclosure information not submitted.
Will Data-Driven Regulatory Science Stimulate Innovation and Initiate a New Regulatory Paradigm?
Friday, May 12, 2023
12:00 – 13:00 CEST